Journal of Therapeutic Ultrasound

Table 1 Demographics of subjects undergoing treatment with the ExAblate 2000 and 2100 systems

From: Safety and treatment volumes achieved following new developments of the magnetic resonance-guided focused ultrasound system in the treatment of uterine fibroids: a cohort study

		ExAblate 2000 (n = 238)	ExAblate 2100 (n = 34)	p Value
Age	Mean years (range)	42.2 (25–84)	39.47 (25–52)	0.26^a
BMI	Mean (SD)	25.1 (4.6)	23.41 (3.79)	0.038^a
Race	White, N (%)	135 (48.0)	14 (41.18)	0.01^b
	Black, N (%)	76 (27.0)	12 (35.30)	0.01^b
	Asian, N (%)	18 (6.4)	8 (23.52)	0.01^b
	Arabic, N (%)	7 (2.5)	0	0.01^b
	Mixed, N (%)	4 (1.4)	0	0.01^b
Parity	Mean (SD)	0.51 (0.89)	0.38 (0.82)	0.328^c
Symptom severity score	Mean (SD)	62.64 (17.80)	61.71 (17.86)	0.841^c
Hyper-intense fibroids	N (%)	67 (28.2)	6 (17.6)	0.196^b
Previous treatment	N (%)	43 (15.4)	5 (13.9)	0.88^b
Number of fibroids	Mean (SD)	6.43 (6.54)	4.18 (3.85)	0.044^c
Mean uterine volume	ml (SD)	788.12 (408.01)	659.62 (259.91)	0.093^c

BMI body mass index.
^aTwo-tailed t test.
^bChi-square test.
^cMann-Whitney test.

Back to article page

ISSN: 2050-5736

Contact us

General enquiries: info@biomedcentral.com